Ohio’s Cannabis Market Is Undersupplied: $3.7B in Sales Meets Limited Retail Capacity — Why Investors Are Paying Attention

As of April, Ohio has generated $331.8 million in cannabis sales in 2026 alone, with $282.4 million coming from adult-use purchases and $49.3 million from medical marijuana. All-time sales have now surpassed $3.7 billion across more than 40.8 million transactions, signaling a market with real scale and sustained consumer demand.

But beneath that growth, a structural imbalance is emerging. Demand is established, but supply is still catching up.

A $3.7 Billion Market Still Building Its Retail Base

Ohio’s cannabis infrastructure continues to expand, but it remains far from saturated.

The state currently operates 209 dual-use dispensaries, supported by 37 cultivators, 46 processors, and six testing laboratories. Additional licenses are already in the pipeline, including 11 provisional dispensary licenses and 61 additional provisional approvals, pointing to continued retail expansion.

Even so, the system is still in buildout mode.

For a market that has already crossed the $3.7 billion threshold in total sales, the number of active retail locations remains relatively limited. That gap between market size and retail footprint is beginning to define how the industry operates in Ohio, a dynamic highlighted in recent analysis by Zuanic & Associates.

Demand Is Established — And Still Growing

The consumer base behind that growth is both large and active.

Ohio has 469,870 registered medical marijuana patients, with over 458,000 unique patients making purchases through licensed dispensaries. That level of participation reflects a mature and engaged customer base that predates the adult-use transition.

At the same time, broader market data shows continued expansion, with quarterly cannabis sales reaching approximately $304 million in the first quarter of 2026, marking 22% year over year growth, a signal of recurring, scaled consumption that continues to build even as the market matures.

Limited Supply Is Keeping Prices Elevated

That demand is being met by a supply system that remains tightly controlled, and pricing reflects it.

The average cost of dried cannabis flower in Ohio currently sits at $6.45 per gram, down slightly from $6.61 a year ago. Other market analyses place pricing closer to $5.88 per gram, indicating some normalization, but still above levels seen in more saturated states.

Compared to markets like Michigan, where aggressive retail expansion has driven prices down sharply, Ohio continues to maintain relatively strong pricing power.

Retail Scarcity Is the Core Constraint

The clearest expression of that imbalance seems to be retail density.

Ohio currently operates over 200 dispensaries, with a regulatory cap set at 400 stores statewide. That translates to roughly 17 dispensaries per one million residents, a figure well below other established cannabis markets.

For comparison:

California operates at roughly 32 stores per million
Arizona at approximately 23
New York is near 27
Missouri around 37

Ohio’s lower density signals a market that is still structurally undersupplied, particularly at the retail level.

Expansion is coming.

Strong Store Economics Reinforce the Opportunity

That limited supply is translating directly into strong operator performance.

Cannabis retailers in Ohio are generating approximately $5.8 million in annual revenue per store, placing the state among the higher-performing markets in the country on a per-location basis.

For operators and investors, that metric matters. It reflects limited competition per store, high throughput per location, and a market structure that still supports strong unit economics.

Ohio’s cannabis market includes a group of established multi-state operators such as Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF), Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF), Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF), and Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF), all operating within the state’s tightly controlled, limited-license framework.

Why the Industry Is Focusing on Ohio Right Now

All of these factors are converging at the same time:

strong and growing demand
limited retail supply
elevated pricing relative to peers
and high revenue per store

As a result, operators, investors, and policymakers are increasingly focused on what happens as supply catches up and on whether the current economics can be sustained.

That question is expected to be central at the upcoming Cannabis Market Spotlight: Ohio Valley, where participants will examine store rollout timelines, capital deployment, supply chain bottlenecks, licensing dynamics, and the data shaping pricing and consumer demand.

The Next Phase: Expansion Without Saturation

Ohio’s cannabis market is positioned for continued growth, but that growth will look different from what came before.

Retail expansion is expected to move toward the 400-store cap, gradually increasing access and competition. Pricing will likely adjust as supply expands, but not at the same pace seen in less-regulated markets.

At the same time, demand remains strong, supported by both a large medical base and an expanding adult-use segment, reinforcing a market that continues to scale within defined boundaries. For operators and investors, that translates into real-time decisions around capital, expansion, and positioning, as deals, partnerships, and strategy take shape at the upcoming Cannabis Market Spotlight: Ohio Valley.